Skip to main content
. 2020 Jul 30;21(15):5449. doi: 10.3390/ijms21155449
BBB Blood–Brain Barrier
IDS Iduronate 2-Sulfatase
GAG Glycosaminoglycan
LC-MS/MS Liquid Chromatography-Tandem Mass Spectrometry
HS Heparan Sulfate
DS Dermatan Sulfate
CSF Cerebrospinal Fluid
FACS Fluorescence-Activated Cell Sorting
TfR Transferrin Receptor
LOD Limit of Detection
LLOQ Low Limit of Quantification
MPS II Mucopolysaccharidosis II
ETV Enzyme Transport Vehicle
D0A0 4,5 unsaturated uronic acid residue-N-acetyl glucosamine, HS ∆UA-GluNAc
D0S0 4,5 unsaturated uronic acid residue-glucosamine-N-sulfate, ∆UA-GluNS
D0a4 4,5 unsaturated uronic acid residue-N-acetyl galactosamine, 4-O-sulfate, ∆UA-GalNAc4S
DQC Dilution Quality Control
HQC High Quality Control
LQC Low Quality Control
MQC Medium Quality Control